Liliana Nordbakk
Partner @ Neva SGR
San Jose, United States
Liliana Nordbakk is a Series B investor at Neva SGR in San Jose focused on Medical and Health Care. Serial entrepreneur and investor in high-tech and biotech companies, with a demonstrated history of building several companies from inception to IPO. Her experience as an entrepreneur and executive comes from building companies that develop Big Data and Artificial Intelligence software products. She co-founded these companies and grew them as anexecutive to exit them either in a trade sale or (IPO). Experienced in investing for more than a decade of building a successful angel investment portfolio with the angel investment group Band of Angels, LLC in San Francisco. As a hands-on investor, Liliana mentors her portfolio companies in the areas of my expertise which are Biotechnologies, Business Development, Corporate Strategy, Management, and Finance.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Liliana Nordbakk invests in
Stages Liliana Nordbakk invests in
Countries Liliana Nordbakk invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
- Therapeutics 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics. | $131.8M / Series B / Jul 10, 2025 |
Co-Investors
About Neva SGR
Neva SGR, part of the Intesa Sanpaolo Group and wholly owned by the Intesa Sanpaolo Innovation Center, plans and manages investment funds for professional investors interested in seizing diversification and high-yield opportunities offered by Venture Capital investments. Neva SGR can count on Intesa Sanpaolo Innovation Center’s and Intesa SanpaoloGroup’s strength, financial resources, know-how and network of relationships, a unique source of value on the market. Neva SGR is the perfect blend of strength, reputation and stability of the Intesa Sanpaolo Group and the best practices of international venture capital firms. Neva SGR aims to boost the Italian economy through new technologies and to be market maker of the VC asset class of venture capital in Italy.
Neva SGR Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alberto Greppi
Senior Investor
|
|||
Cosimo Scarinci
Investment Team Member
|
|||
Antonio Chiarello
Key Man - NEVA FIRST Fund
|
|||
|
Liliana Nordbakk
Partner
|
|||
Mario Costantini
CEO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Liliana Nordbakk invest in?
Liliana Nordbakk invests primarily in Medical, Health Care and Therapeutics startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Liliana Nordbakk?
Public channels for Liliana Nordbakk include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Liliana Nordbakk last invest?
The most recent investment recorded for Liliana Nordbakk closed in Jul 2025. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
